Now that 2023 is underway, key trends are emerging that will shape the healthcare landscape against an uncertain economic backdrop and lingering pandemic-related challenges. For payers and providers, inflation and other economic woes are…
Continue Reading
By Mark Melchionna
March 09, 2023 – Published in PLOS ONE, a recent study described how a team of researchers at Massachusetts General Hospital (MGH) developed and validated an artificial intelligence (AI) model, specifically…
Chartis and DES Health Consulting form the Chartis Center for Burnout Solutions to support caregivers in increasingly tenuous work environments
Today, Chartis, a comprehensive healthcare advisory firm, announced it has established the Chartis Center for Burnout…
Continue Reading
Public health agencies that communicated clearly, led with science, and provided protective resources were able to build patient trust more than those agencies that appeared to be politically motivated, according to a new report…
Continue Reading
The Cost of Doing Nothing: Five Learnings from the Build versus Buy DebateBy Kimberly Hartsfield
Kimberly Hartsfield, MPA is EVP of growth enablement at VisiQuate of Santa Rosa, CA.
It’s a conundrum that health…
Continue Reading
By Mark Melchionna March 01, 2023 – Published in the March Issue of Plastic and Reconstructive Surgery, new research provided evidence surrounding the demographic characteristics, such as income, race, and area of…
Continue Reading
COVID-19 forced a spike in policy-makers’ interest and willingness to invest in public health; a spike that is unfortunately retreating to the old business as usual. (President Biden, in his State of the Union…
Continue Reading
Researchers at the Harvard Wyss Institute are collaborating with a biotechnology company called Gameto to develop human ovarian organoids that will allow the study of reproductive and other health issues using tissues that closely…
Continue Reading
Researchers at the Harvard Wyss Institute and the Dana-Farber Cancer Institute have developed a new method to prepare chimeric antigen receptor-T cells (CAR-T cells) for leukemia patients that could result in more effective treatment. CAR-T cells start life as T cells that are isolated from cancer patients, are stimulated and primed to recognize and attack cancer cells, expanded in number, and then reintroduced to the cancer patient with the goal that the cells will destroy their cancer. However, the technique works better in certain patients, and the researchers behind this latest technique have realized that T-cells from cancer patients do […]…
Continue Reading
Researchers at the Harvard Wyss Institute have developed an electrochemical device, called the eRapid sensor, that can assist clinicians in quickly characterizing someone’s COVID-19 infection, including identifying the infecting viral variant and the nature of someone’s immunity to the virus in terms of whether it is vaccine-mediated or natural immunity. Monitoring these characteristics could help to personalize treatment for individuals and also provide data for drug development and inform government decisions on the best way to manage COVID-19 in the community. When antibodies from a blood sample bind within the device, it precipitates a biochemical cascade that affects the electrical […]…
Continue Reading
